Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$82.14 - $91.0 $1.28 Million - $1.42 Million
-15,634 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$80.93 - $91.1 $218,430 - $245,878
2,699 Added 20.87%
15,634 $1.37 Million
Q1 2020

May 06, 2020

BUY
$70.67 - $99.01 $914,116 - $1.28 Million
12,935 New
12,935 $1.07 Million
Q4 2019

Feb 11, 2020

SELL
$84.35 - $95.37 $1.37 Million - $1.55 Million
-16,260 Closed
0 $0
Q3 2019

Nov 07, 2019

SELL
$85.54 - $94.26 $1.89 Million - $2.09 Million
-22,130 Reduced 57.65%
16,260 $1.41 Million
Q2 2019

Jul 25, 2019

BUY
$75.4 - $92.8 $2.89 Million - $3.56 Million
38,390 New
38,390 $3.51 Million
Q2 2018

Aug 07, 2018

SELL
$64.91 - $73.36 $596,328 - $673,958
-9,187 Closed
0 $0
Q1 2018

May 04, 2018

BUY
$70.39 - $84.15 $646,672 - $773,086
9,187 New
9,187 $743,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.